IL15 and neoplasm: In other reports, the anti-tumor efficacy of T cells was enhanced either via in vivo administration of IL-15 + IL-21 (118) or conjugation of nanoparticles, encapsulating these cytokines, to the surface of therapeutic T cells (119).